These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17641826)

  • 1. Long-term follow-up study of patients with phenylketonuria detected by the newborn screening programme in Japan.
    Aoki K; Ohwada M; Kitagawa T
    J Inherit Metab Dis; 2007 Aug; 30(4):608. PubMed ID: 17641826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
    Didycz B; Lemańska D; Słuszniak A
    Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of effectiveness and outcome of PKU screening and management in the State of Sergipe, Brazil.
    Ramalho AR; Ramalho RJ; Oliveira CR; Magalhães MM; Santos EG; Sarmento PM; Matos DO; Oliveira MC; Oliveira AL; Aguiar-Oliveira MH
    Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):62-7. PubMed ID: 24728166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn phenylketonuria (PKU) Guthrie (BIA) screening and early hospital discharge.
    Hanley WB; Demshar H; Preston MA; Borczyk A; Schoonheyt WE; Clarke JT; Feigenbaum A
    Early Hum Dev; 1997 Jan; 47(1):87-96. PubMed ID: 9118832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC for confirmatory diagnosis and biochemical monitoring of Cuban patients with hyperphenylalaninemias.
    Contreras J; Alonso E; Fuentes LE
    MEDICC Rev; 2015 Jan; 17(1):23-8. PubMed ID: 25725765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary management practices in phenylketonuria across European centres.
    Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
    Clin Nutr; 2009 Jun; 28(3):231-6. PubMed ID: 19362397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated phenylalanine on newborn screening: follow-up testing may reveal undiagnosed galactosaemia.
    Shakespeare L; Downing M; Allen J; Casbolt AM; Ellin S; Maloney M; Race G; Bonham J
    Ann Clin Biochem; 2010 Nov; 47(Pt 6):567-9. PubMed ID: 20947531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal phenylalanine wash-out in phenylketonuria.
    Porta F; Ponzone A; Spada M
    Metab Brain Dis; 2020 Oct; 35(7):1225-1229. PubMed ID: 32661828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening: a national public health programme in Brazil.
    de Carvalho TM; dos Santos HP; dos Santos IC; Vargas PR; Pedrosa J
    J Inherit Metab Dis; 2007 Aug; 30(4):615. PubMed ID: 17694357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
    Cechák P; Hejcmanová L; Rupp A
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S59-63. PubMed ID: 8828612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
    Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
    Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues in newborn screening for phenylketonuria.
    Koch RK
    Am Fam Physician; 1999 Oct; 60(5):1462-6. PubMed ID: 10524490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What disorders suspect following an increase of phenylalanine on newborn screening?].
    Michel MA; Raucourt E; Bednarek N; Garnotel R
    Ann Biol Clin (Paris); 2014; 72(2):193-6. PubMed ID: 24736139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the Phenylalanine Cut-Off Value in a Newborn Screening Program.
    Perko D; Repic Lampret B; Remec ZI; Zerjav Tansek M; Drole Torkar A; Krhin B; Bicek A; Oblak A; Battelino T; Groselj U
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early blood sampling in neonatal programs for the detection of phenylketonuria.
    Szeinberg A; Cohen BE
    Padiatr Padol; 1982; 17(2):287-92. PubMed ID: 7099682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening 50 years later: access issues faced by adults with PKU.
    Berry SA; Brown C; Grant M; Greene CL; Jurecki E; Koch J; Moseley K; Suter R; van Calcar SC; Wiles J; Cederbaum S
    Genet Med; 2013 Aug; 15(8):591-9. PubMed ID: 23470838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of early detected and early treated phenylketonuria patients.
    Rylance G
    Postgrad Med J; 1989; 65 Suppl 2():S7-9. PubMed ID: 2622815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insurance Reimbursement for Special Foods and Phenylalanine Levels in Patients With PKU in China.
    Wang B; Xia Y; Cheng M; Luo H; Xue L; Gong A; Liu X; Liao G; Song J; Ning K
    JAMA Netw Open; 2024 Jun; 7(6):e2412886. PubMed ID: 38837161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key European guidelines for the diagnosis and management of patients with phenylketonuria.
    van Spronsen FJ; van Wegberg AM; Ahring K; Bélanger-Quintana A; Blau N; Bosch AM; Burlina A; Campistol J; Feillet F; Giżewska M; Huijbregts SC; Kearney S; Leuzzi V; Maillot F; Muntau AC; Trefz FK; van Rijn M; Walter JH; MacDonald A
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):743-756. PubMed ID: 28082082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with phenylketonuria receiving tetrahydrobiopterin treatment.
    Trefz FK; Scheible D; Frauendienst-Egger G
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S163-9. PubMed ID: 20217238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.